http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2016152821-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174 |
| filingDate | 2016-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2016152821-A1 |
| titleOfInvention | A treatment for dry eye associated with Sjogren's syndrome |
| abstract | The present invention relates to a pharmaceutical composition for the treatment of dry eye associated with Sjogren's syndrome, comprising ozagrel or a pharmacologically acceptable salt thereof as an active ingredient. The pharmaceutical composition of the present invention is a treatment for dry eye cornea and conjunctival epithelial disorder associated with Sjogren's syndrome, which has a strong tendency to remain after instillation of a general dry eye treatment (eg, artificial tears). In particular, it exhibits an excellent therapeutic effect. Therefore, the pharmaceutical composition of the present invention is useful as a pharmaceutical composition for treating dry eye associated with Sjogren's syndrome. |
| priorityDate | 2015-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.